Laboratory Biorisk Management
272,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

Setting the stage for a substantively different approach for managing the risks of working with biological agents in laboratories, this book defines biorisk management and explains how to implement it. The basis for this new paradigm is a three-pronged, multidisciplinary model of assessment, mitigation, and performance (the AMP model). The application of the methodologies, criteria, and guidance outlined in this book will reduce the risk of laboratories becoming the sources of infectious disease outbreaks. It will also significantly improve the safety and security of laboratories that work with infectious diseases.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Setting the stage for a substantively different approach for managing the risks of working with biological agents in laboratories, this book defines biorisk management and explains how to implement it. The basis for this new paradigm is a three-pronged, multidisciplinary model of assessment, mitigation, and performance (the AMP model). The application of the methodologies, criteria, and guidance outlined in this book will reduce the risk of laboratories becoming the sources of infectious disease outbreaks. It will also significantly improve the safety and security of laboratories that work with infectious diseases.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Edited by Reynolds M. Salerno is the senior manager for Cooperative Threat Reduction Programs at Sandia National Laboratories in Albuquerque, New Mexico. These programs enhance security by reducing biological, chemical, and nuclear threats worldwide. Reynolds M. Salerno received his PhD from Yale University. Recognized as a leading expert on laboratory biosecurity, Dr. Salerno and his Sandia team have worked extensively in laboratory biosafety, biosecurity, biocontainment, and infectious disease diagnostics and control internationally. As a technical advisor to the World Health Organization (WHO), he was a member of its international team which inspected the Maximum Containment (smallpox) Laboratory at the State Research Center of Virology and Biotechnology VECTOR in Koltsovo, Russia. He recently held the position of vice chairman of the board of directors of the International Federation of Biosafety Associations. Jennifer Gaudioso leads the International Biological Threat Reduction and International Chemical Threat Reduction programs at Sandia National Laboratories in Albuquerque, New Mexico. These programs enhance US and international security by promoting safe, secure, and responsible use of dangerous biological and chemical agents. The team currently consults in more than 40 countries specifically on biosecurity and chemical security issues. Jennifer Gaudioso earned her PhD in chemistry from Cornell University. Dr. Gaudioso and her Sandia team work with international partners, such as the World Health Organization and the International Federation of Biosafety Associations. Dr. Gaudioso is the author of numerous journal articles and has presented her research at national and international meetings.